Sign In

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.

The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by binding to the same receptor. This prevents the agonist drug from activating the receptor and producing its intended effect. For example, naloxone, a competitive antagonist, can block the effects of opioid drugs by binding to opioid receptors and reversing their activation.

In addition, functional or physiological antagonism occurs when a drug binds to a different receptor and produces a physiological response that opposes the effect of the agonist-bound receptor. For example, histamine stimulates acid secretion, while omeprazole prevents acid secretion by inhibiting the proton pump. These drugs can be considered functional antagonists.

Some drugs follow chemical antagonism, which involves the combination of two drugs to form an inactive product. Examples include chelating agents like dimercaprol, which bind to heavy metals and reduce their toxicity. The neutralizing antibody infliximab, which sequesters the inflammatory cytokine tumor necrosis factor (TNF), has an anti-inflammatory effect.

Antagonism can also occur through pharmacokinetic interactions, where one drug affects another drug's absorption, distribution, metabolism, or elimination. For instance, if a drug increases the metabolism or elimination of another drug, it can decrease the concentration and effectiveness of the second drug, leading to antagonistic effects.

Tags
AntagonismDrug InteractionReceptor BindingAllosteric ModulationFunctional InteractionChemical ReactionsPharmacokinetic ProcessesReceptor AntagonismCompetitive AntagonistOpioid ReceptorsPhysiological AntagonismChelating AgentsInfliximabTumor Necrosis Factor TNFDrug Metabolism

From Chapter 4:

article

Now Playing

4.14 : Combined Effects of Drugs: Antagonism

Pharmacodynamics

7.5K Views

article

4.1 : مبادئ العمل الدوائي

Pharmacodynamics

5.4K Views

article

4.2 : أهداف الإجراءات المتعلقة بالمخدرات: نظرة عامة

Pharmacodynamics

5.2K Views

article

4.3 : نقل الإشارة: نظرة عامة

Pharmacodynamics

8.0K Views

article

4.4 : آلية محول الطاقة: مستقبلات G المقترنة بالبروتين

Pharmacodynamics

1.6K Views

article

4.5 : مستقبل القناة الأيونية ذات البوابات الترابطية: آلية البوابات

Pharmacodynamics

1.9K Views

article

4.6 : آلية محول الطاقة: مستقبلات مرتبطة بالإنزيم

Pharmacodynamics

2.2K Views

article

4.7 : آلية محول الطاقة: المستقبلات النووية

Pharmacodynamics

1.2K Views

article

4.8 : العلاقة بين الجرعة والاستجابة: نظرة عامة

Pharmacodynamics

2.7K Views

article

4.9 : العلاقة بين الجرعة والاستجابة: الفعالية والفعالية

Pharmacodynamics

3.9K Views

article

4.10 : العلاقة بين الجرعة والاستجابة: الانتقائية والخصوصية

Pharmacodynamics

6.1K Views

article

4.11 : المؤشر العلاجي

Pharmacodynamics

3.8K Views

article

4.12 : تفاعل مستقبلات المخدرات: ناهض

Pharmacodynamics

2.2K Views

article

4.13 : التفاعل بين الدواء والمستقبلات: المضاد

Pharmacodynamics

2.4K Views

article

4.15 : الآثار المشتركة للأدوية: التآزر

Pharmacodynamics

3.0K Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved